Scope Fluidics S.A. (WSE:SCP)
138.00
+0.20 (0.15%)
Apr 16, 2026, 4:49 PM CET
Scope Fluidics Revenue
In the year 2025, Scope Fluidics had annual revenue of 100.00K PLN, down -23.66%. Scope Fluidics had revenue of -598.00K in the quarter ending December 31, 2025.
Revenue
100.00K
Revenue Growth
-23.66%
P/S Ratio
4,372.21
Revenue / Employee
757.58
Employees
132
Market Cap
437.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.00K | -31.00K | -23.66% |
| Dec 31, 2024 | 131.00K | -385.00K | -74.61% |
| Dec 31, 2023 | 516.00K | 112.00K | 27.72% |
| Dec 31, 2022 | 404.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.64B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 706.45M |
| Mercator Medical | 585.57M |
| BIOTON | 282.52M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 87.70M |